If You Invested $5,000 in Vaxart In January, This Is How Much You Would Have Today

At the start of the year, Vaxart (NASDAQ: VXRT) was a biotech company with a market cap of about $17 million and a stock price of less than $1. Once the company entered the coronavirus vaccine race, however, its fortunes -- and those of its investors -- changed. The stock has since pared its gains; rivals moved closer to the coronavirus vaccine finish line and Vaxart didn't receive Operation Warp Speed (OWS) funding as some investors had hoped.